Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page: https://medlineplus.gov/lab-tests/calcitonin-test/

Calcitonin Test

What is a calcitonin test?

A calcitonin test uses a sample of your blood to measure your levels of calcitonin, a hormone made in your thyroid gland by cells called “C cells.” Your thyroid is a small, butterfly-shaped gland in your neck, and C cells grow on the inside part of your thyroid (the medulla).

Usually, if you have too much calcium in your blood, your thyroid will release calcitonin to bring those levels down. But if your thyroid makes more calcitonin than your body needs, or your thyroid makes too much calcitonin even when you don't have high calcium levels, it may be a sign of:

  • Medullary thyroid cancer (MTC), a rare cancer that happens when C cells in your thyroid grow out of control
  • C-cell hyperplasia, a rare, benign (not cancer) condition that causes abnormal growth of C cells in your thyroid and that may turn into MTC

Other names: thyrocalcitonin, CT, human calcitonin, hCT

What is it used for?

A calcitonin test is most often used to:

  • Help diagnose C-cell hyperplasia and medullary thyroid cancer in people who have symptoms
  • Find out if treatment for medullary thyroid cancer is working
  • Check whether medullary thyroid cancer has returned after treatment
  • Screen people who have a family history of C-cell hyperplasia, MTC, or a rare genetic disorder called multiple endocrine neoplasia type 2 (MEN 2)

There are different types of MEN 2 that often cause tumors in certain glands that make hormones, including your thyroid. All types of MEN 2 increase your risk of medullary thyroid cancer. MEN 2 is caused by changes in a gene called RET. Changes in genes are also called gene variants or mutations.

You can inherit MEN 2 – and therefore an increased risk for medullary thyroid cancer – if either of your parents passed a changed RET gene down to you. If MEN 2 runs in your family, your provider may frequently order calcitonin tests to help find cancer early when it may be easier to treat.

Why do I need a calcitonin test?

You may need a calcitonin test if you have:

  • Symptoms of medullary thyroid cancer or C-cell hyperplasia
  • Symptoms of multiple endocrine neoplasia type 2 (MEN 2)
  • A family history of MEN 2
  • Been diagnosed with medullary thyroid cancer and are receiving, or have completed, treatment

Symptoms of medullary thyroid cancer or C-cell hyperplasia may include:

  • A lump in the front of your neck
  • Swollen lymph nodes in your neck (also called “swollen glands”)
  • Pain in your throat
  • Trouble swallowing or breathing
  • A change in your voice, such as hoarseness
  • A long-lasting cough when you don't have a cold
  • Diarrhea

Generally, providers don't use calcitonin tests to look for medullary thyroid cancer or C-cell hyperplasia unless you have symptoms. This is because both conditions are very rare.

Symptoms of multiple endocrine neoplasia type 2 (MEN 2) can affect your thyroid, adrenal, and parathyroid glands. Symptoms depend on which glands are affected. They may include:

If MEN 2 runs in your family, you and your family members, including children, may need frequent calcitonin tests to help find cancer before you have symptoms. Your provider may also suggest a blood test to check for changes in your RET genes that cause MEN 2.

If you've been diagnosed with medullary thyroid cancer, you'll need calcitonin testing to:

  • Find out how well your treatment is working
  • Check whether the cancer has come back after you finish treatment

What happens during a calcitonin test?

A health care professional will take a blood sample from a vein in your arm, using a small needle. After the needle is inserted, a small amount of blood will be collected into a test tube or vial. You may feel a little sting when the needle goes in or out. This usually takes less than five minutes.

Your provider may order a calcitonin stimulation test to see how your calcitonin levels change in real time. To do this, they will collect an initial blood sample (called a baseline) before giving you medicine to make your body produce calcitonin. The medicine is injected into a vein intravenously (by IV). Afterwards, your provider will take several more blood samples to measure the effects of the medicine on your calcitonin production.

Will I need to do anything to prepare for the test?

You may need to fast (not eat or drink) for several hours before the test. Your provider will let you know if you need to fast and if there are any special instructions to follow.

Are there any risks to the test?

There is very little risk to having a blood test. You may have slight pain or bruising at the spot where the needle was put in, but most symptoms go away quickly.

What do the results mean?

The meaning of your calcitonin test results depends on the reason you were tested. If you had a calcitonin test:

To help diagnose or screen for medullary thyroid cancer or C-cell hyperplasia:

  • A normal calcitonin level may mean that you don't have either condition, but it doesn't rule them out. That's because medullary thyroid cancer and C-cell hyperplasia don't always cause high calcitonin. Your provider may order other tests to learn more.
  • A high calcitonin level means that the C cells in your thyroid are making too much calcitonin. The higher the level, the more likely it is that you have medullary thyroid cancer or C-cell hyperplasia. However, high calcitonin levels may be caused by other conditions, including certain other cancers, certain medicines, and pregnancy. So, to make a diagnosis, your provider will consider other information, including other test results.
  • A low calcitonin level is not known to cause health problems.

To monitor treatment for medullary thyroid cancer or to check whether cancer has come back after treatment: The meaning of your test results depends on the type of treatment you're having or had. Treatment usually starts with surgery to remove your thyroid gland. Other treatments include radiation therapy, chemotherapy, and/or medicines.

In general:

  • Calcitonin levels that decrease and stay low over time usually mean that your treatment is helping.
  • A calcitonin level that decreases but is still higher than normal may mean that you still have some cancer tissue left in your body. You may need more tests and treatment.
  • A calcitonin level that increases over time usually means that your cancer has returned or spread to other parts of your body.

Ask your provider to explain what your test results mean for your health.

Learn more about laboratory tests, reference ranges, and understanding results.

References

  1. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2026. Tests for Thyroid Cancer; [updated 2024 Aug 23; cited 2026 May 20]; [about 10 screens]. Available from: https://www.cancer.org/cancer/thyroid-cancer/detection-diagnosis-staging/how-diagnosed.html
  2. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2026. What Is Thyroid Cancer?; [updated 2024 Aug 23; cited 2026 May 20]; [about 9 screens]. Available from: https://www.cancer.org/cancer/thyroid-cancer/about/what-is-thyroid-cancer.html
  3. Cleveland Clinic: Health Library: Diagnostics & Testing [Internet]. Cleveland (OH): Cleveland Clinic; c2026. Calcitonin; [reviewed 2025 Jan 7; cited 2026 May 20]; [about 3 screens]. Available from: https://my.clevelandclinic.org/health/articles/22330-calcitonin
  4. Cleveland Clinic: Health Library: Diagnostics & Testing [Internet]. Cleveland (OH): Cleveland Clinic; c2026. Medullary Thyroid Cancer (MTC); [reviewed 2025 Jan 16; cited 2026 May 20]; [about 4 screens]. Available from: https://my.clevelandclinic.org/health/diseases/22873-medullary-thyroid-cancer-mtc
  5. Cleveland Clinic: Health Library: Diagnostics & Testing [Internet]. Cleveland (OH): Cleveland Clinic; c2026. Multiple Endocrine Neoplasia (MEN); [reviewed 2022 May 23; cited 2026 May 20]; [about 10 screens]. Available from: https://my.clevelandclinic.org/health/diseases/23088-multiple-endocrine-neoplasia-men
  6. Master SR, Burns B. Medullary Thyroid Cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. [Updated 2024 Nov 10; cited 2026 May 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459354/
  7. Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research; c1998–2026. Thyroid cancer: Diagnosis and treatment; [reviewed 2025 Dec 23; cited 2026 May 20]; [about 22 screens]. Available from: https://www.mayoclinic.org/diseases-conditions/thyroid-cancer/diagnosis-treatment/drc-20354167
  8. Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research; c1998–2026. Thyroid cancer: Symptoms and causes; [reviewed 2025 Dec 23; cited 2026 May 20]; [about 16 screens]. Available from: https://www.mayoclinic.org/diseases-conditions/thyroid-cancer/symptoms-causes/syc-20354161
  9. Mayo Clinic: Mayo Medical Laboratories [Internet]. Mayo Foundation for Medical Education and Research; c1995–2026. Test ID: CATN: Calcitonin, Serum: Clinical and Interpretive; [cited 2026 May 20]; [about 3 screens]. Available from: https://www.mayocliniclabs.com/test-catalog/overview/9160#Clinical-and-Interpretive
  10. National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; NCI Dictionary of Cancer Terms: calcitonin; [cited 2026 May 20]; [about 1 screens]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/calcitonin
  11. National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; NCI Dictionary of Cancer Terms: multiple endocrine neoplasia type 2 syndrome; [cited 2026 May 20]; [about 2 screens]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multiple-endocrine-neoplasia-type-2-syndrome
  12. National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Pheochromocytoma; [posted 2020 Feb 12; cited 2026 May 20]; [about 3 screens]. Available from: https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/pheochromocytoma
  13. National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Thyroid Cancer Screening (PDQ®)- Patient Version; [updated 2025 May 13; cited 2026 May 20]; [about 8 screens]. Available from: https://www.cancer.gov/types/thyroid/patient/thyroid-screening-pdq
  14. Johns Hopkins Medicine [Internet]. The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System; c2026. Health: Blood Test; [cited 2026 May 20]; [about 3 screens]. Available from: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/blood-test
  15. National Center for Advancing Translational Sciences: Genetic and Rare Diseases Information Center [Internet]. Gaithersburg (MD): U.S. Department of Health and Human Services; Multiple endocrine neoplasia type 2; [updated 2026 May; cited 2026 May 20]; [about 11 screens]. Available from: https://rarediseases.info.nih.gov/diseases/3830/multiple-endocrine-neoplasia-type-2
  16. National Center for Advancing Translational Sciences: Genetic and Rare Diseases Information Center [Internet]. Gaithersburg (MD): U.S. Department of Health and Human Services; Medullary Thyroid carcinoma; [updated 2026 May; cited 2026 May 20]; [about 10 screens]. Available from: https://rarediseases.info.nih.gov/diseases/7004/thyroid-cancer-medullary
  17. National Organization for Rare Disorders [Internet]. Danbury (CT): NORD-National Organization for Rare Disorders; c2026. Multiple Endocrine Neoplasia Type 2; [reviewed 2024 May 13; cited 2026 May 20]; [about 18 screens]. Available from: https://rarediseases.org/rare-diseases/multiple-endocrine-neoplasia-type
  18. Testing.com [Internet]. Seattle (WA): OneCare Media; c2026. Calcitonin; [modified 2020 Nov 6; cited 2026 May 20]; [about 10 screens]. Available from: https://www.testing.com/tests/calcitonin/
  19. Yasir M, Mulji NJ, Kasi A. Multiple Endocrine Neoplasias Type 2. [Updated 2026 Apr 12; cited 2026 May 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519054/

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.